Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. [electronic resource] by
- Choe, Jung-Yoon
- Prodanovic, Nenad
- Niebrzydowski, Jaroslaw
- Staykov, Ivan
- Dokoupilova, Eva
- Baranauskaite, Asta
- Yatsyshyn, Roman
- Mekic, Mevludin
- Porawska, Wieskawa
- Ciferska, Hana
- Jedrychowicz-Rosiak, Krystyna
- Zielinska, Agnieszka
- Choi, Jasmine
- Rho, Young Hee
- Smolen, Josef S
Producer: 20170606
In:
Annals of the rheumatic diseases vol. 76
Availability: No items available.
|
|
18.
|
Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study. [electronic resource] by
- Smolen, Josef S
- Choe, Jung-Yoon
- Prodanovic, Nenad
- Niebrzydowski, Jaroslaw
- Staykov, Ivan
- Dokoupilova, Eva
- Baranauskaite, Asta
- Yatsyshyn, Roman
- Mekic, Mevludin
- Porawska, Wieslawa
- Ciferska, Hana
- Jedrychowicz-Rosiak, Krystyna
- Zielinska, Agnieszka
- Lee, Younju
- Rho, Young Hee
Producer: 20190128
In:
Annals of the rheumatic diseases vol. 77
Availability: No items available.
|
|
19.
|
Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results. [electronic resource] by
- Smolen, Josef S
- Choe, Jung-Yoon
- Prodanovic, Nenad
- Niebrzydowski, Jaroslaw
- Staykov, Ivan
- Dokoupilova, Eva
- Baranauskaite, Asta
- Yatsyshyn, Roman
- Mekic, Mevludin
- Porawska, Wieskawa
- Ciferska, Hana
- Jedrychowicz-Rosiak, Krystyna
- Zielinska, Agnieszka
- Choi, Jasmine
- Rho, Young Hee
Producer: 20171006
In:
Rheumatology (Oxford, England) vol. 56
Availability: No items available.
|